Modifi Bio
Signal active
Organization
Contact Information
Overview
Modifi Biosciences is a leader in direct DNA modification and the development of novel cancer therapeutics. The company's strategy for combating cancer centers around modifying tumor DNA in a way that renders cancer cells irreparable while preserving the integrity of healthy cells. This unique approach empowers researchers to disrupt traditional oncology drug development methods.
About
Industries
Biotechnology, Medical, Therapeutics
Founded
2021
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Modifi Bio headquartered in United States, North America, operates in the Biotechnology, Medical, Therapeutics sector. The company focuses on Biotechnology and has secured $471.6M in funding across 36 round(s). With a team of 11-50 employees, Modifi Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Modifi Bio, raised $4.3M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
3
Investors
7
Lead Investors
0
Total Funding Amount
$13.1M
Details
2
Modifi Bio has raised a total of $13.1M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Seed | 6.4M | ||
| 2023 | Seed | 4.3M |
Investors
Modifi Bio is funded by 18 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Modifi Bio | - | FUNDING ROUND - Modifi Bio | 4.3M |
| BrightEdge Fund | - | FUNDING ROUND - BrightEdge Fund | 4.3M |
| Modifi Bio | - | FUNDING ROUND - Modifi Bio | 4.3M |
| Sontag Family Trust | - | FUNDING ROUND - Sontag Family Trust | 4.3M |
Recent Activity
There is no recent news or activity for this profile.